Johnson & Johnson (J&J) experienced difficulties keeping up to date on the global drug pipeline and spent considerable time and expense gathering and analyzing data from multiple sources, so it turned to Cortellis Competitive Intelligence
for help.
J&J’s top drivers for subscribing included:
- More pipeline data than anywhere else – 73 K+ pipeline drug programs
- More early phase pipeline data than anywhere else – 20 K+ assets
- Depth and breadth of global coverage – drug programs and companies from 100+ countries
- Accuracy and timeliness of data
The post Making data driven decisions with reliable intelligence appeared first on Cortellis.